Bellevue Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66K | Hold |
49
| – | – | ﹤0.01% | 380 |
|
|
2025
Q1 | $3.11K | Buy |
49
+11
| +29% | +$699 | ﹤0.01% | 380 |
|
|
2024
Q4 | $2.97K | Hold |
38
| – | – | ﹤0.01% | 409 |
|
|
2024
Q3 | $3.05K | Hold |
38
| – | – | ﹤0.01% | 375 |
|
|
2024
Q2 | $3.14K | Hold |
38
| – | – | ﹤0.01% | 364 |
|
|
2024
Q1 | $3.24K | Hold |
38
| – | – | ﹤0.01% | 359 |
|
|
2023
Q4 | $3.25K | Hold |
38
| – | – | ﹤0.01% | 351 |
|
|
2023
Q3 | $3.4K | Hold |
38
| – | – | ﹤0.01% | 330 |
|
|
2023
Q2 | $3.24K | Hold |
38
| – | – | ﹤0.01% | 352 |
|
|
2023
Q1 | $3.14K | Buy |
38
+4
| +12% | +$331 | ﹤0.01% | 360 |
|
|
2022
Q4 | $2.65K | Hold |
34
| – | – | ﹤0.01% | 365 |
|
|
2022
Q3 | $3K | Hold |
34
| – | – | ﹤0.01% | 347 |
|
|
2022
Q2 | $2K | Hold |
34
| – | – | ﹤0.01% | 409 |
|
|
2022
Q1 | $2K | Sell |
34
-8
| -19% | -$471 | ﹤0.01% | 455 |
|
|
2021
Q4 | $2K | Sell |
42
-3
| -7% | -$143 | ﹤0.01% | 493 |
|
|
2021
Q3 | $3K | Buy |
45
+24
| +114% | +$1.6K | ﹤0.01% | 457 |
|
|
2021
Q2 | $1K | Sell |
21
-2
| -9% | -$95 | ﹤0.01% | 569 |
|
|
2021
Q1 | $3K | Sell |
23
-3
| -12% | -$391 | ﹤0.01% | 507 |
|
|
2020
Q4 | $3K | Buy |
+26
| New | +$3K | ﹤0.01% | 518 |
|